Given HMGB1's role in the coagulopathy associated with sepsis, it may serve as a potential therapeutic target for anticoagulant treatment, with interventions aimed at HMGB1 potentially improving the coagulation function in septic patients. Here, HMGB1 is linked to Sepsis.